Albertsons Companies (ACI) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
10 Jan, 2026Executive summary
Q3 FY24 delivered 2% identical sales growth, 23% digital sales growth, and a 15% increase in loyalty members to 44.3 million, despite a cautious consumer environment and the termination of the Kroger merger.
Net sales rose 1.2% to $18.77 billion, with net income at $401 million ($0.69/share) and adjusted net income at $420 million ($0.71/share), aided by an $81 million discrete state tax benefit.
Adjusted EBITDA was $1.065 billion (5.7% of revenue), down year-over-year due to higher costs and lower fuel sales.
Strategic focus remains on digital engagement, technology modernization, and productivity, with continued investment in core business and talent.
The Kroger merger was terminated after court injunctions; litigation and a $600 million termination fee are pending.
Financial highlights
Gross margin was 27.9%, down from 28.0% year-over-year, mainly due to pharmacy and digital mix.
SG&A rate rose to 25.1% of revenue, up 6 bps ex-fuel, driven by merger and occupancy costs.
Interest expense fell to $109 million, reflecting lower debt.
Net income benefited from an $81 million discrete state tax benefit, lowering the effective tax rate to 3.5%.
Capital expenditures were $494 million in Q3 and $1.45 billion for the first 40 weeks, focused on store modernization and digital/tech platforms.
Quarterly dividend increased 25% to $0.15 per share; $70 million returned to shareholders via dividends in Q3.
Net debt leverage at quarter-end was 1.9x.
Outlook and guidance
FY24 identical sales growth expected at 1.8%-2.0% (narrowed from 1.8%-2.2%).
Adjusted EBITDA guidance raised to $3.95-$3.99 billion (from $3.90-$3.98 billion).
Adjusted EPS guidance increased to $2.25-$2.31 per share.
Full-year tax rate expected at 15%-16% due to discrete tax benefit.
Capex guidance unchanged at $1.8-$1.9 billion.
2025 outlook to be provided in April.
Latest events from Albertsons Companies
- Identical sales and digital growth lifted revenue, but margins narrowed amid ongoing investments.ACI
Q1 20259 Jan 2026 - Q3 2025 saw 2.4% identical sales growth, strong digital gains, and major capital actions.ACI
Q3 20257 Jan 2026 - Q2 2025 saw 2.0% revenue growth, higher net income, and a $750M share buyback announcement.ACI
Q2 20257 Jan 2026 - Q4 delivered strong digital and pharmacy growth, but margin pressure tempers 2025 optimism.ACI
Q4 202419 Dec 2025 - Board recommends against all shareholder proposals; focus remains on digital growth and ESG impact.ACI
Proxy Filing1 Dec 2025 - Annual meeting to vote on directors, auditor, and pay, with focus on merger, governance, and ESG.ACI
Proxy Filing1 Dec 2025 - Annual proxy statement outlines voting items and confirms standard shareholder meeting.ACI
Proxy Filing1 Dec 2025 - Definitive additional proxy materials filed for shareholder voting, with no fee required.ACI
Proxy Filing1 Dec 2025 - All directors attended at least 75% of board and committee meetings in fiscal 2024.ACI
Proxy Filing1 Dec 2025